By Heather Landi
Federal agencies warn that cybercriminals are escalating their extortion attempts against the healthcare sector even as hospitals are facing a nationwide surge in COVID-19 cases. Several U.S. hospitals have already been targeted in ransomware attacks this week. Here are the key threat details you need to know.
read more
By Fraiser Kansteiner
Lonza is plowing ahead in the COVID fight with production work on Moderna's mRNA-based vaccine and Humanigen's monoclonal antibody lenzilumab. Now, it's signed on to manufacture AstraZeneca's dual-antibody hopeful, AZD7442, too.
read more
By Conor Hale
By casting a broad, digital net to pick up the signs of coronavirus outbreaks, researchers hope to build an early warning system that uses data from people’s wearable activity trackers.
read more
By Beth Snyder Bulik
Telehealth is surging during the pandemic. And with estimates pegging telehealth growth at as much as 80% in 2020, it’s not an area pharma can afford to ignore. Ironwood Pharmaceuticals and Evofem Biosciences aren't. Top commercial executives from both companies discussed how they're using telehealth to engage with patients and ease their path to prescriptions at Digital Pharma Innovation Week.
read more
By Tina Reed
Here's a look at which specialties are still seeing the most growth even as Doximity reports average compensation is essentially down due to inflation.
read more
By Heather Landi
Telehealth giant Teladoc completed its massive $18.5 billion acquisition of Livongo, the company announced Friday. The deal was wrapped up quickly, in under three months, as the companies likely look to leverage the current financial tailwinds of the telehealth boom and investor interest in digital health spurred by the COVID-19 pandemic.
read more
By Eric Sagonowsky
Novo Nordisk entered 2020 with big expectations around its oral diabetes med Rybelsus, and while the pandemic has slowed the launch some, other meds have carried the day and propelled the company to revenue growth.
read more
By Paige Minemyer
COVID-19 has dramatically accelerated the adoption of digital health, and a new analysis from Deloitte finds that trend extends similarly to Medicare Advantage beneficiaries.
read more
By Heather Landi
Providers are getting an additional five months to comply with new regulations aimed at improving data sharing. The Trump administration issued an interim final rule Thursday that extends the compliance deadlines for healthcare information blocking and interoperability regulations.
read more
By Eric Sagonowsky,Angus Liu,Kyle Blankenship,Conor Hale,Fraiser Kansteiner
Regeneron may stop enrolling the sickest patients in one of its antibody trials due to safety concerns. Novo's Rybelsus is rebounding from a pandemic sales hit. Activity trackers could help detect COVID, Scripps research found. States lack funding for a national shot rollout. And Israel will kick off a human trial of its vaccine Sunday.
read more
